Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
Overall activity in deals jumped 11% in North America.
For founders and owners of privately held medical product businesses, the amount of private investment dollars available is significant.
The company is dedicating more funds to research, development and innovative projects.
The deal will help strengthen the Edwards portfolio of smart monitoring technologies.
The union will strengthen BD’s leadership in medication management and infection prevention, and increase opportunities in fast-growing clinical areas and OUS markets.
The company is performing well across all business units and geographies.
Foreign device companies can expect a big opportunity for expansion in Southeast Asia.
The deal creates the largest global sterilization and lab services operation.
Shift the odds in your favor.